BR112022004293A2 - Géis termofixantes de liberação sustentada compreendendo bloqueadores de canais de sódio e os métodos para fazer o mesmo - Google Patents

Géis termofixantes de liberação sustentada compreendendo bloqueadores de canais de sódio e os métodos para fazer o mesmo

Info

Publication number
BR112022004293A2
BR112022004293A2 BR112022004293A BR112022004293A BR112022004293A2 BR 112022004293 A2 BR112022004293 A2 BR 112022004293A2 BR 112022004293 A BR112022004293 A BR 112022004293A BR 112022004293 A BR112022004293 A BR 112022004293A BR 112022004293 A2 BR112022004293 A2 BR 112022004293A2
Authority
BR
Brazil
Prior art keywords
methods
doing
same
sustained release
sodium channel
Prior art date
Application number
BR112022004293A
Other languages
English (en)
Inventor
Ami Jo
Derek Jackson John
Neil Bodick
Rebecca Senter
Scott Kelley
Ujjwal Joshi
Original Assignee
Pacira Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacira Therapeutics Inc filed Critical Pacira Therapeutics Inc
Publication of BR112022004293A2 publication Critical patent/BR112022004293A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

a presente divulgação fornece composições compreendendo uma formulação de hidrogel termossensível de funapida e um polímero de tribloco e métodos de uso e fabricação das composições para controle de dor aguda ou dor associada ao procedimento cirúrgico.
BR112022004293A 2019-09-09 2020-09-09 Géis termofixantes de liberação sustentada compreendendo bloqueadores de canais de sódio e os métodos para fazer o mesmo BR112022004293A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962897555P 2019-09-09 2019-09-09
US201962932076P 2019-11-07 2019-11-07
US202062958212P 2020-01-07 2020-01-07
US202063026369P 2020-05-18 2020-05-18
PCT/US2020/049826 WO2021050470A1 (en) 2019-09-09 2020-09-09 Sustained release thermosetting gels comprising sodium channel blockers and the methods of making the same

Publications (1)

Publication Number Publication Date
BR112022004293A2 true BR112022004293A2 (pt) 2022-06-21

Family

ID=74866804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004293A BR112022004293A2 (pt) 2019-09-09 2020-09-09 Géis termofixantes de liberação sustentada compreendendo bloqueadores de canais de sódio e os métodos para fazer o mesmo

Country Status (6)

Country Link
US (1) US20220296719A1 (pt)
EP (1) EP4027979A4 (pt)
JP (1) JP2022547532A (pt)
CN (1) CN114980866A (pt)
BR (1) BR112022004293A2 (pt)
WO (1) WO2021050470A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022192427A1 (en) * 2021-03-10 2022-09-15 Pacira Therapeutics, Inc. Sustained release thermosetting gels comprising sodium channel blockers and the methods of making the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
CN1774237A (zh) * 2003-03-21 2006-05-17 尼克美制药控股有限公司 前列腺素组合物及其促进血管生成的方法
CN105726531A (zh) * 2010-02-26 2016-07-06 泽农医药公司 用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途
CN104606129B (zh) * 2015-01-21 2018-05-04 中国人民解放军广州军区武汉总医院 罗哌卡因长效注射用温敏凝胶及其制备方法
KR20180014778A (ko) * 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
US20170239183A1 (en) * 2016-02-23 2017-08-24 PixarBio Corporation COMPOSITIONS COMPRISING NAv1.7 SELECTIVE INHIBITORS FOR TREATING ACUTE, POST-OPERATIVE, OR CHRONIC PAIN AND METHODS OF USING THE SAME
CA3026885A1 (en) * 2016-06-16 2017-12-21 Xenon Pharmaceuticals Inc. Solid state forms of spiro-oxindole compounds

Also Published As

Publication number Publication date
CN114980866A (zh) 2022-08-30
EP4027979A1 (en) 2022-07-20
US20220296719A1 (en) 2022-09-22
WO2021050470A1 (en) 2021-03-18
EP4027979A4 (en) 2023-10-04
JP2022547532A (ja) 2022-11-14

Similar Documents

Publication Publication Date Title
BR112015019440A8 (pt) curativo regulável, kit, uso e método para fortalecimento da pele
PE20200494A1 (es) Polinucleotidos de aadc para el tratamiento de la enfermedad de parkinson
BR112019008016A2 (pt) implante com lâminas mobilizáveis
EP3560524A4 (en) DRY GEL SPONGE OF SUPERWATER ABSORBING POLYMER HYDROGEL, METHOD OF MANUFACTURING THEREFORE AND USE OF IT
BR112015020804A2 (pt) dispositivo fototerapeutico, método e uso
BR112017021396A2 (pt) composição em gel, filme e método para aplicação de uma composição em gel
BR112019008323A2 (pt) implante de fusão espinhal
EP3981393A4 (en) TISSUE ADHESIVE BIOMIMETIC HYDROGEL PATCH AND ITS USE
BR112016028866A2 (pt) dispositivos para vedação de grampos em tecidos
BR112013021486A2 (pt) lentes de contato de hidrogel contendo fosfina
GT201100195A (es) Derivados de sulfonamida
BR112015023760A2 (pt) compostos e composições terapêuticas
BR112018016520A2 (pt) sistemas médicos de matriz-pixel, dispositivos e métodos
BR112017002879A2 (pt) balões revestidos e conjuntos de balões revestidos e métodos relacionados de uso e fabricação
BR112017017346A2 (pt) implantes para esculpir, aumentar ou corrigir atributos faciais tais como o queixo
CY1124596T1 (el) Φαρμακευτικη συνθεση τραμαδολης για οφθαλμικη χρηση
BR112018007006A2 (pt) tetra-hidropiranilsulfonas substituídas por pirazolil
CL2017002214A1 (es) Formulación de combinación de tesofensina y betabloqueante
CY1120642T1 (el) Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση
BR112017006406A2 (pt) composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico
BR112018010622A2 (pt) dispositivos, sistemas e métodos de engate de tecido
BR112022004293A2 (pt) Géis termofixantes de liberação sustentada compreendendo bloqueadores de canais de sódio e os métodos para fazer o mesmo
BR112018013350A2 (pt) composição para remoção de películas de cosmético e composições de maquiagem, e, método para remoção de uma película de cosmético ou composição de maquiagem de fibras queratinosas.
CO2019004131A2 (es) Glicinato de metformina, composiciones farmacéuticas que comprenden la misma, y métodos de uso de la misma
BR112015009476A2 (pt) dispositivo de alívio de pressão tendo uma linha de abertura definida a laser

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]